Before 2010, a Zimbabwean baby born to a mother living with HIV had a one in four chance of becoming infected. In 2014, the odds had fallen to one in fifteen. During this period Zimbabwe made huge progress in preventing mother-to-child transmission of HIV (PMTCT) with strong support from EGPAF. The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) became committed to this journey in 2001 and was the Zimbabwe’s Ministry of Health and Child Care’s (MOHCC) most supportive ally in its gains toward elimination of mother-to-child HIV transmission. To date EGPAF Zimbabwe has implemented multiple projects in support of the PMTCT program and to maintain the gains made to date.
Explore Related Resources
February 2022, HEALTH CENTER OF MACIA, Locality Macia, District of Xai Xai, Gaza Province, Mozambique. A doctor smiling AND doctor in a consultation
Journal Articles
HPV Vaccination Uptake and Acceptability of HPV/HIV Integrated Services Models for Adolescent Girls in Mozambique and Zimbabwe
Published June 2026
This study found that integrating HPV vaccination into HIV prevention and treatment services in Mozambique and Zimbabwe significantly increased vaccine uptake among girls at heightened risk of HPV and cervical cancer, while achieving high caregiver acceptance and satisfaction with the integrated care model.
View Resource
Topics:
Adolescents,
HIV
Countries:
Mozambique,
Zimbabwe
Project Brief
Digital Health at the Elizabeth Glaser Pediatric AIDS Foundation
Published November 2024
The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) partners with ministries of health to design, develop, deploy, and maintain national health information ecosystems. A proven leader in the fight to end HIV and AIDS, EGPAF’s experience shows that digital health solutions—and the strategic data we’re able to capture and leverage—will be key to reaching and sustaining […]
View Resource
Topics:
General
Adolescents join for a field day at Lobamba clinic in Eswatini
Journal Articles
Follow-Up Outcomes of Children, Adolescents, and Young People on Darunavir-Based Third-Line Antiretroviral Therapy
Published October 2024
Background: We assessed clinical outcomes among children, adolescents, and people younger than 25 years on darunavir-based antiretroviral therapy (ART) in 9 sub-Saharan African countries. Setting: Third-line ART centers in Cameroon, Eswatini, Kenya, Lesotho, Nigeria, Rwanda, Uganda, Zambia, and Zimbabwe. Methods: From January 2019 to December 2022, we collected data from a cohort of children, adolescents, and young people […]
View Resource
Topics:
Adolescents,
Pediatric HIV
Countries:
Cameroon,
Eswatini,
Kenya,
Lesotho,
Nigeria,
Rwanda,
Uganda,
Zambia,
Zimbabwe